6550--Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers
ID: 36C26325Q0328Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 23 (36C263)Saint Paul, MN, 55101, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/444cd81c08f14a28b1ed5607383b294d/view
Timeline
    Description

    The Department of Veterans Affairs intends to negotiate a sole source contract with Microgenics Corporation for the procurement of FDA-approved Microgenics DRI Ecstasy Plus Assay Reagent, which is essential for use with Beckman AU480 Analyzers at the Minneapolis VA Medical Center. This contract action is being pursued under the authority of FAR 13.106-1, which allows for sole source awards when only one source is available to meet the government's requirements. The reagents are critical for in-vitro diagnostic testing, ensuring accurate and timely results for patient care. Interested vendors who believe they can meet the requirements are invited to submit a capability statement by 12:00 PM Central Time on January 9, 2025, to Alisha Milander at Alisha.Milander@va.gov, with all submissions needing to include registration details in the System for Award Management (SAM).

    Point(s) of Contact
    Alisha MilanderContracting Officer
    701-239-3700 x3176
    Alisha.Milander@va.gov
    Files
    Title
    Posted
    36C26325Q0328.docx
    The document is a presolicitation notice from the Department of Veterans Affairs announcing the government’s intention to negotiate a sole source contract with Microgenics Corporation. This contract aims to procure FDA-approved Microgenics DRI Ecstasy Plus Assay Reagent for use with Beckman AU480 Analyzers at the Minneapolis VA Medical Center. The action follows FAR guidelines, specifically FAR 13.106-1, allowing for sole source awards. Interested parties who believe they can fulfill the requirements may submit a capability statement by the deadline of January 9, 2025. All responses must include sufficient information to verify the vendor's capabilities, including registration details in the System for Award Management (SAM). The government retains the discretion to decide whether to proceed with competition based on the responses received. Overall, this notice outlines the procurement strategy for essential medical supplies while providing a pathway for potential vendors to demonstrate their qualifications.
    Similar Opportunities
    6640--NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract to Illumina, Inc. for the provision of molecular testing reagents required by the Minneapolis VA Health Care System. This procurement involves a Firm Fixed Price Purchase Order for a base year plus four option years, specifically for next-generation sequencing reagents that are compatible with the VA's existing Illumina sequencers. The sole-source justification is based on the fact that Illumina is the only authorized supplier for these specialized reagents, with no alternative products approved for use on the VA's equipment. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by January 10, 2025, to the Contracting Officer, Traci Johannes, at traci.johannes@va.gov.
    6630--Notice of Intent - Sole Source Bridge Contract - Integrated Chemistry CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source bridge contract to Beckman Coulter, Inc. for an integrated chemistry Cost-Per-Reportable Result (CPRR) program. This procurement includes equipment rental and maintenance services, as well as 103 different chemistry and immunochemistry tests, ensuring the provision of necessary reagents, controls, and consumables for the Central Texas Veterans Health Care System. The contract is crucial for maintaining laboratory operations during the transition to new equipment analyzers, with the anticipated period of performance from January 15, 2025, to October 14, 2025. Interested parties may submit capability statements for consideration within seven days of this notice, after which the contract will be finalized with Beckman Coulter, Inc. if no other responses are received. For further inquiries, contact Kathryn Prose at kathryn.prose@va.gov or (254) 217-2835.
    Lab Reagents for Pathology Dept. at WRNMMC
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Roche Diagnostics Corporation for the procurement of specialized lab reagents and consumables necessary for molecular diagnostics testing in the Pathology Department at Walter Reed National Military Medical Center (WRNMMC). This procurement is critical for testing viral pathogens and is supported under the authority for non-competitive purchases, as Roche is the sole supplier of the proprietary materials required for use with the existing Roche medical equipment at WRNMMC. Interested parties may submit their qualifications by January 10, 2025, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil. The government retains discretion over the contract award process and is not obligated to seek competitive bids despite any expressions of interest received.
    6640--06 BACT/ALERT VIRTUO Blood Culture System, Consumables, and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to establish a sole-source Indefinite Delivery Indefinite Quantity (IDIQ) contract for the BACT/ALERT VIRTUO Blood Culture System, including necessary consumables and support services, to be utilized across multiple laboratories within VISN 6. This procurement aims to ensure the provision of a fully automated blood culture testing system, which is critical for healthcare services provided to veterans, with the contract expected to commence on November 29, 2024. The decision to pursue a sole-source contract with BioMerieux Incorporated follows market research indicating that these specialized items are exclusively available from the original equipment manufacturer, thereby avoiding delays and additional costs. Interested parties may express their capabilities to Contract Specialist Stephanie McElmore via email by November 19, 2024, and should clearly indicate their business status regarding size and ownership.
    6550--NEW | CTX ABL 90 Reagents and Consumables
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply reagents and consumables for venous and arterial blood gas testing using ABL90 analyzers at the Central Texas Veterans Health Care System. The procurement aims to establish a firm-fixed price, indefinite delivery/indefinite quantity (IDIQ) contract for a five-year period, ensuring compliance with the Buy American Act. This acquisition is crucial for enhancing medical testing services for veterans, as the reagents and consumables will support the operation of three ABL90 analyzers recently purchased for the facility. Interested parties must respond to the Request for Information (RFI) by January 10, 2025, and can direct inquiries to Contract Specialist Ognian D. Ivanov at Ognian.Ivanov@va.gov.
    Sources Sought Phadia Test Kits and Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 5, is seeking sources for the procurement of Phadia test kits and supplies, including reagents for its ImmunoCap Allergy and ELiA Autoimmunity solutions. This Sources Sought Notice is intended for planning purposes only and will not result in a contract award; it aims to gather information on available suppliers and their capabilities. The anticipated procurement will be structured as a firm-fixed-price Indefinite Delivery Indefinite Quantity contract, potentially spanning five years, with deliveries to the VAMHCS Baltimore warehouse. Interested suppliers must respond by January 6, 2025, providing company details and socio-economic status to Alison Klein at ALISON.KLEIN@VA.GOV.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    Special Notice- Intent to Sole Source Award the Purchase of Lab Instruments to Agilent Technologies Inc.
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Contracting Command – Aberdeen Proving Ground, intends to award a sole source contract to Agilent Technologies Inc. for the purchase of specialized lab instruments, namely the Seahorse XF and xCELLigence systems. These instruments are essential for conducting precise physiological measurements critical to military ration development and ongoing research efforts at the U.S. Army Combat Capabilities Development Command – Soldier Center. The procurement is justified based on the unique capabilities of Agilent's systems, which are not available from other vendors, and is necessary to avoid significant operational setbacks in military research missions. Interested parties may express their interest and capabilities by contacting Edmund J. Bousaleh and Alejandro Ayala via email by 1500 HRS ET on January 14, 2025, with the contract funded through Research, Development, Test, and Evaluation (RDT&E) for fiscal year 2024.
    6515--Equipment - Neutralization Station - Detroit
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to CS Medical, LLC for the procurement of two TEEClean Automated TEE Probe Cleaners and associated accessories for the John D. Dingell VA Medical Center in Detroit, MI. This acquisition, valued at approximately $77,763.78, is necessitated by the need to transition from an inefficient manual cleaning process to an automated system that enhances hygiene and operational effectiveness. The unique capabilities of CS Medical as the sole manufacturer and distributor of the required disinfection equipment have been confirmed through extensive market research, underscoring the urgency and specificity of this requirement. Interested parties must submit any responses by email to LouAnn Gilliland at louann.gilliland@va.gov no later than 12:00 PM EST on January 10, 2025, as competitive proposals are not being solicited.